Given the role of PTK2 and c-MET in ETV1-meditated metastasis and the discovery of the HGF-ETV1-c-MET loop, we speculated that c-MET inhibitors might cooperate with PTK2 inhibitors in targeting ETV1-overexpressing HCC. The gene discussed is PTK2; the disease is hepatocellular carcinoma.